SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

81,106.65 107.25
( 0.13%)

Global Indices

Nasdaq

51,462.04 -82.02
(-0.16%)

Dow Jones

7,424.83 50.10
(0.68%)

Hang Seng

58,738.13 1,303.36
(2.27%)

Nikkei 225

10,662.59 -120.07
(-1.11%)

Forex

USD-INR

94.41 -0.18
(-0.19%)

EUR-INR

106.07 -0.23
(-0.22%)

GBP-INR

127.18 -0.23
(-0.18%)

JPY-INR

0.60 0.00
(-0.04%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Infinium Pharmachem Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

78690

INE0MRE01011

74.2654051

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

INFINIUM

42.78

428.61

EPS(TTM)

Face Value()

Div & Yield %

6.43

Back

ITC consolidated net profit declines 18.68% in the September 2026 quarter

Nov 03,2026

Net profit of ITC declined 18.68% to Rs 4168.40 crore in the quarter ended September 2026 as against Rs 5126.11 crore during the previous quarter ended September 2025. Sales rose 4.29% to Rs 20121.24 crore in the quarter ended September 2026 as against Rs 19293.22 crore during the previous quarter ended September 2025.

Particulars	Quarter Ended
	Sep. 2026	Sep. 2025	% Var.
Sales	20121.24	19293.22	4
OPM %	28.05	34.70	-
PBDT	6210.88	7325.40	-15
PBT	5720.28	6890.60	-17
NP	4168.40	5126.11	-19

81,106.65 107.25 ( 0.13%)

51,462.04 -82.02 (-0.16%)

7,424.83 50.10 (0.68%)

58,738.13 1,303.36 (2.27%)

10,662.59 -120.07 (-1.11%)

94.41 -0.18 (-0.19%)

106.07 -0.23 (-0.22%)

127.18 -0.23 (-0.18%)

0.60 0.00 (-0.04%)